Veristat will be attending Clinical Trials Europe 2019, the conference formerly known as the Partnerships in Clinical Trial Europe conference, for the first time this year.
Are your risk-management strategies for clinical trials E6 (R2) Compliant? Learn how to be sure.
AMWA 2019 | 7 Habits of Highly Successful Medical Writers
October 8, 2019
Join Veristat at AMWA 2019 Medical Writing & Communication Conference to learn about the trends and opportunities in the field of medical writing and medical communications.
Webinar Summary
Patient recruitment continues to be the number one reason for study delays. It is estimated for every day a drug is not on the market, $1 million USD is lost in revenue, and more importantly, patients suffering from illnesses are left waiting for products that can help them achieve their health goals or provide a better quality of life.Veristat to Speak on Risk-Based Monitoring At MassBio Forum
September 18, 2019
Join Veristat and panel of experts at the upcoming MassBio Forum:
Veristat to Speak on Successful Sponsor/CRO Partnerships at Evolution Summit Fall 2019
August 29, 2019
Veristat is excited to be heading to the Evolution Summit Fall 2019 taking place on Sept 11-13, 2019 in San Diego, CA. We will be co-hosting a Master Class session on Successful Sponsor/CRO Partnerships.
Meet Veristat at booth #21 at the upcoming OCT Southern California 2019 event taking place in San Diego, CA from September 24-25, 2019.
We provide impactful strategies and solutions to meet your outsourcing needs in order to plan and run your next clinical trial, program or regulatory submission project.
Webinar Summary
Accelerating the development of therapeutic products intended to treat serious conditions has been an interest of the public, legislators, and the scientific community for many years.Webinar | Managing R2 (E6) Compliance As it Relates to Risk
August 2, 2019
Webinar Summary
As of December 2016, the International Council for Harmonisation (ICH) adopted the revised E6 guideline, entitled “Integrated Addendum to Good Clinical Practice (GCP).” The new regulations within E6(R2) require the Sponsor to manage their study using a risk-based approach.
Veristat To Exhibit at PharmaSUG China 2019
July 29, 2019
Veristat is excited to attend and exhibit at PharmaSUG China 2019 for the first time. This event is the premier event of the year for statistical programmers, statisticians, data managers, researchers, and others who analyze data in the life sciences. Meet Veristat at Booth #7!